Login to Your Account



Approval Rates Don’t Help

Filings and Review Times Increase FDA Approvals

By Brian Orelli
Contributing Writer

Monday, December 2, 2013

The FDA approved 35 new molecular/biological entities (NMEs/NBEs) on average in 2011-2012, substantially higher than the 20-year average of 28 approvals.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription